GLP1R and hydrops fetalis: In conclusion, GLP-1 receptor agonists may be particularly beneficial for HF patients, especially those with established atherosclerotic cardiovascular disease and preserved EF, as they offer significant benefits and are generally well tolerated, with mainly minor gastrointestinal side effects such as nausea, vomiting, and diarrhea [245].